ProPhase Labs

(NASDAQ) PRPH

Current PriceN/A

Market CapN/A

Since IPO (1992)-95%

5 YearN/A

1 YearN/A

1 Month+33%

ProPhase Labs Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$1.08M

Net Income (TTM)

$41.70M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

PRPH News

ProPhase Labs Posts Narrower Q2 Loss

Motley Fool Markets TeamAug 13, 2025

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About ProPhase Labs

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

Ted William Karkus, MBA

Website

www.prophaselabs.com

Headquarters

Garden City, NY 11530, US

PRPH Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

-25%

Net Income Margin

-39%

Return on Equity

-4%

Return on Capital

-3%

Return on Assets

-63%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$150.00K

Operating Income

$38.63M

EBITDA

$32.34M

Operating Cash Flow

$17.54M

Capital Expenditure

$906.00K

Free Cash Flow

$18.44M

Cash & ST Invst.

$678.00K

Total Debt

$24.57M

ProPhase Labs Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q3 2025YOY CHG

Revenue

$883.00K

-71.9%

Gross Profit

$123.00K

+25.5%

Gross Margin

-13.93%

N/A

Market Cap

N/A

Market Cap/Employee

N/A

Employees

N/A

Net Income

$6.84M

-3.8%

EBITDA

$4.39M

+19.1%

Quarterly Fundamentals

Name

Q3 2025YOY CHG

Net Cash

$7.28M

+74.5%

Accounts Receivable

$3.28M

-89.6%

Inventory

$266.00K

-93.3%

Long Term Debt

$965.00K

-95.6%

Short Term Debt

$6.72M

-10.9%

Return on Assets

-63.47%

N/A

Return on Invested Capital

-2.58%

N/A

Free Cash Flow

$21.52M

-411.7%

Operating Cash Flow

$21.52M

-434.1%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

AYTUAytu BioPharma, Inc.

AYTUAytu BioPharma, Inc.$2.50+1.21%

TXMDTherapeuticsMD, Inc.

TXMDTherapeuticsMD, Inc.$1.98-1.49%

ERNAErnexa Therapeutics Inc.

ERNAErnexa Therapeutics Inc.$7.53-3.71%

BFRIBiofrontera Inc.

BFRIBiofrontera Inc.$1.15+0.88%

ADAPAdaptimmune Therapeutics plc

ADAPAdaptimmune Therapeutics plc$0.05-3.00%

AEMDAethlon Medical, Inc.

AEMDAethlon Medical, Inc.$2.26-1.74%

CODXCo-Diagnostics, Inc.

CODXCo-Diagnostics, Inc.$2.53+31.09%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

INTCIntel

INTCIntel$124.88+0.14%

RXTRackspace Technology

RXTRackspace Technology$5.49+0.56%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$15.37+0.06%

POETPoet Technologies

POETPoet Technologies$10.88+0.14%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$76.00+0.07%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$42.77-0.06%

AALAmerican Airlines Group

AALAmerican Airlines Group$13.29+0.01%

Questions About PRPH

What is the current price of ProPhase Labs?

ProPhase Labs is trading at N/A per share.

What is the 52-week range for ProPhase Labs?

Over the past 52 weeks, ProPhase Labs has traded between N/A and N/A.

How much debt does ProPhase Labs have?

As of the most recent reporting period, ProPhase Labs reported total debt of $10.62M.

How much cash does ProPhase Labs have on hand?

ProPhase Labs reported $90,000 in cash and cash equivalents in its most recent financial results.

What is ProPhase Labs’s dividend yield?

ProPhase Labs does not currently have a dividend yield.

ProPhase Labs

ProPhase Labs Financials at a Glance

PRPH News

ProPhase Labs Posts Narrower Q2 Loss

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About ProPhase Labs

PRPH Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

ProPhase Labs Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About PRPH

What is the current price of ProPhase Labs?

What is the 52-week range for ProPhase Labs?

How much debt does ProPhase Labs have?

How much cash does ProPhase Labs have on hand?

What is ProPhase Labs’s dividend yield?

Premium Investing Services